Overview
John Matthews is an Ophthalmologist in Greensboro, North Carolina. Dr. Matthews is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Retinal Vein Occlusion, Retinal Artery Occlusion, Diabetic Retinopathy, and Age-Related Macular Degeneration (ARMD). Dr. Matthews is currently accepting new patients.
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1313 Carolina St, Suite 103, Greensboro, NC 27401
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Carolina Eye Associates PA
Paula Pecen is an Ophthalmologist in Greensboro, North Carolina. Dr. Pecen is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. Her top areas of expertise are Uveitis, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Trabeculectomy. Dr. Pecen is currently accepting new patients.
Piedmont Retina Specialists PA
Charles Richards is an Ophthalmologist in Greensboro, North Carolina. Dr. Richards is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, and Diabetic Retinopathy. Dr. Richards is currently accepting new patients.
Piedmont Retina Specialists PA
Kishan Govind is an Ophthalmologist in Greensboro, North Carolina. Dr. Govind is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Artery Occlusion, and Retinal Vein Occlusion. Dr. Govind is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Age-Related Macular Degeneration (ARMD)
- Diabetic RetinopathyDr. Matthews isAdvanced. Learn about Diabetic Retinopathy.
- Retinal Artery OcclusionDr. Matthews isAdvanced. Learn about Retinal Artery Occlusion.
- Retinal Vein OcclusionDr. Matthews isAdvanced. Learn about Retinal Vein Occlusion.
- Experienced
- Central Serous ChorioretinopathyDr. Matthews isExperienced. Learn about Central Serous Chorioretinopathy.
- Choroid Plexus CarcinomaDr. Matthews isExperienced. Learn about Choroid Plexus Carcinoma.
- Geographic AtrophyDr. Matthews isExperienced. Learn about Geographic Atrophy.
- Jalili SyndromeDr. Matthews isExperienced. Learn about Jalili Syndrome.
- Kallikrein HypertensionDr. Matthews isExperienced. Learn about Kallikrein Hypertension.
- Late-Onset Retinal DegenerationDr. Matthews isExperienced. Learn about Late-Onset Retinal Degeneration.